Atai Beckley N.V. (ATAI) Discusses BPL-003 Phase IIb Open-Label Extension Study Results in Treatment Resistant Depression Transcript

Group 1 - The conference call is focused on the Atai Beckley BPL-003 phase IIb open-label extension study data [1] - The call includes forward-looking statements that are subject to risks and uncertainties [1] - The company does not undertake any obligation to revise or update forward-looking statements unless required by law [1] Group 2 - Factors that could cause actual results to differ from forward-looking statements are discussed in detail in the recently filed 10-K [2]